Literature DB >> 34220008

No Association Between a Genetic Variant of FOXO3 and Risk of Type 2 Diabetes Mellitus in the Elderly Population of North India.

Sartaj Hussain1, Kanak Lata Dwivedi1, Suraj Singh Yadav1, Kauser Usman2, Rajendra Nath1, Sanjay Khattri1.   

Abstract

Aging can be considered an evolutionary process that is modulated by various genetic and biochemical processes. Therefore the genetic variants may interplay a role in human longevity as well as age related illness. Forkhead Box O (FOXO) gene is one of the major defensive genes that are known for ameliorating lifespan. FOXO proteins act as nuclear transcription factors that facilitate the action of insulin or insulin-like growth factor (IGF-1) in various physiological processes. The rationale of our study is to find out association between genetic variant rs2253310 of FOXO3 and risk of Type 2 Diabetes Mellitus (T2DM) in elderly population. This case control study involved 172 age sex matched elderly subjects while patients were recruited as per IDF criteria. Clinical, biochemical, ELISA methods were employed for assesement of clinical samples while Taqman method was used for genotyping analysis. Our results revealed that there was no significant difference in genotypic and allelic frequencies for the tested SNP (p > 0.05) between elderly T2DM patients and controls. The SNP rs2253310 was not associated with risk of T2DM in any genetic model. Also no association was found among the studied group between FOXO3 variant and HOMA-IR, HOMA-B index and Fasting plasma glucose. Serum level of inflammatory markers like CRP and TNF-α was significantly higher in patients but its not associated with SNP rs2253310. Our study concluded that, this intronic longevity-associated variant rs2253310 in FOXO3 is not associated with type 2 diabetes in geriatric patients of northern India. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  FOXO3; Geriatric; Type 2 Diabetes Mellitus; rs2253310

Year:  2020        PMID: 34220008      PMCID: PMC8215020          DOI: 10.1007/s12291-020-00917-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

1.  FOXO3-NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function.

Authors:  Matthew G Thompson; Michelle Larson; Amy Vidrine; Kelly Barrios; Flor Navarro; Kaitlyn Meyers; Patricia Simms; Kushal Prajapati; Lennox Chitsike; Lance M Hellman; Brian M Baker; Stephanie K Watkins
Journal:  J Immunol       Date:  2015-11-11       Impact factor: 5.422

2.  Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance.

Authors:  Annette M Chang; Marla J Smith; Andrzej T Galecki; Cathie J Bloem; Jeffrey B Halter
Journal:  J Clin Endocrinol Metab       Date:  2006-06-06       Impact factor: 5.958

3.  Association analysis of common variants in FOXO3 with type 2 diabetes in a South Indian Dravidian population.

Authors:  Anup Kumar Nair; Divya Sugunan; Harish Kumar; Gopalakrishnapillai Anilkumar
Journal:  Gene       Date:  2011-10-12       Impact factor: 3.688

4.  Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study.

Authors:  Nathalie de Rekeneire; Rita Peila; Jingzhong Ding; Lisa H Colbert; Marjolein Visser; Ronald I Shorr; Stephen B Kritchevsky; Lewis H Kuller; Elsa S Strotmeyer; Ann V Schwartz; Bruno Vellas; Tamara B Harris
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

5.  Association Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.

Authors:  Brian J Morris; Randi Chen; Timothy A Donlon; Daniel S Evans; Gregory J Tranah; Neeta Parimi; Georg B Ehret; Christopher Newton-Cheh; Todd Seto; D Craig Willcox; Kamal H Masaki; Kei Kamide; Hirochika Ryuno; Ryosuke Oguro; Chikako Nakama; Mai Kabayama; Koichi Yamamoto; Ken Sugimoto; Kazunori Ikebe; Yukie Masui; Yasumichi Arai; Tatsuro Ishizaki; Yasuyuki Gondo; Hiromi Rakugi; Bradley J Willcox
Journal:  Am J Hypertens       Date:  2016-11-01       Impact factor: 2.689

6.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

7.  Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress.

Authors:  Weijia Luo; Jin Cao; Jie Li; Weimin He
Journal:  Exp Gerontol       Date:  2007-11-21       Impact factor: 4.032

8.  Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.

Authors:  James C Lee; Marion Espéli; Carl A Anderson; Michelle A Linterman; Joanna M Pocock; Naomi J Williams; Rebecca Roberts; Sebastien Viatte; Bo Fu; Norbert Peshu; Tran Tinh Hien; Nguyen Hoan Phu; Emma Wesley; Cathryn Edwards; Tariq Ahmad; John C Mansfield; Richard Gearry; Sarah Dunstan; Thomas N Williams; Anne Barton; Carola G Vinuesa; Miles Parkes; Paul A Lyons; Kenneth G C Smith
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

9.  Diabetes Management in the Elderly.

Authors:  Erika Leung; Supakanya Wongrakpanich; Medha N Munshi
Journal:  Diabetes Spectr       Date:  2018-08

10.  An association study of FOXO3 variant and longevity.

Authors:  Geralda Gillian Silva-Sena; Daniela Camporez; Lígia Ramos Dos Santos; Aline Sesana da Silva; Lúcia Helena Sagrillo Pimassoni; Alessandra Tieppo; Maria do Carmo Pimentel Batitucci; Renato Lírio Morelato; Flavia de Paula
Journal:  Genet Mol Biol       Date:  2018-06-11       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.